Procedural sedation and analgesia.
Conditions
Interventions
Intervention 1: group A: Propofol-Ketamine administration
Ketamine Hydrochloride (Rotexmedia Trittau-Germany) 0.5 mg/kg
Propofol Lipuro 1% (B. Braun Melsungen AG) 0.5 mg/kg
Repeated half doses every 5
Sponsors
Vice chancellor for research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: All adults of American Society of Anesthesiologist Class (ASA) class I-II of Procedural Sedation and Analgesia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison between 2 sedative regimen efficacy. Timepoint: During sedation for a painful procedure. Method of measurement: Ramsay Sedation Scores are documented in the questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular/respiratory adverse events. Timepoint: During and after sedation (every 5 minutes) up to achievement of baseline Ramsay score. Method of measurement: Cardiac monitoring and pulse oximetry.;Patient and provider satisfaction. Timepoint: After the end of sedation. Method of measurement: Visual Analog Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Maryam Bahreini
Tehran University of Medical Sciences
Outcome results
None listed